CollPlant Biotechnologies
CLGN
6 hedge funds and large institutions have $10.2M invested in CollPlant Biotechnologies in 2020 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 3 closing their positions.
38% more capital invested
Capital invested by funds: $7.42M → $10.2M (+$2.81M)
0.92% more ownership
Funds ownership: 13.76% → 14.69% (+0.92%)
14% less funds holding
Funds holding: 7 → 6 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SDJVC
St. Denis J. Villere & Co
New Orleans,
Louisiana
|
+$364K |
| 2 |
BFEC
Benjamin F. Edwards & Company
St. Louis,
Missouri
|
+$117K |
| 3 |
IMOV
Investment Management of Virginia
Richmond,
Virginia
|
+$80.9K |
| 4 |
PA
Parallel Advisors
San Francisco,
California
|
+$25.8K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$7.84K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$107K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$7K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MIH
1
Meitav Investment House
Bene-Beraq,
Israel
| $5.9M | – | – | – |
|
|
IMOV
2
Investment Management of Virginia
Richmond,
Virginia
| $3.07M | +$80.9K | +10,016 | +4% |
|
|
SDJVC
3
St. Denis J. Villere & Co
New Orleans,
Louisiana
| $946K | +$364K | +45,050 | +105% |
|
|
BFEC
4
Benjamin F. Edwards & Company
St. Louis,
Missouri
| $156K | +$117K | +14,520 | New |
|
|
5
Citadel Advisors
Miami,
Florida
| $126K | +$7.84K | +971 | +9% |
|
|
PA
6
Parallel Advisors
San Francisco,
California
| $34K | +$25.8K | +3,188 | New |
|
|
7
Renaissance Technologies
New York
| – | -$107K | -12,797 | Closed |
|
|
8
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$7K | -836 | Closed |
|
|
9
UBS Group
Zurich,
Switzerland
| – | -$2K | -273 | Closed |
|
CLGN Hedge Fund Activity: Q4 2020 in Review
6 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in CollPlant Biotechnologies (CLGN) for Q4 2020, worth a combined $10.2M — up 38% from $7.42M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CLGN and 2 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 3 added.
The largest buyer was St. Denis J. Villere & Co, adding an estimated $364K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $107K sold.
- 6 institutional investors held CollPlant Biotechnologies (CLGN) as of Q4 2020, down from 7 in Q3 2020.
- Funds reported $10.2M of CollPlant Biotechnologies stock for Q4 2020, up 38% quarter-over-quarter.
- 2 funds opened new CollPlant Biotechnologies positions in Q4 2020 and 3 closed out, a net change of -1 holder.
- The largest CollPlant Biotechnologies buyer in Q4 2020 was St. Denis J. Villere & Co, an estimated $364K added.
- The largest CollPlant Biotechnologies seller in Q4 2020 was Renaissance Technologies, an estimated $107K sold.
Based on aggregated 13F filings for Q4 2020.